Clinical Trial: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomized Trial for the Assessment of Immunogenicity and Safety of Four Different Dosing Regimens of BioThrax® for Post-Exposure Prophylaxis for Anthrax in Adults

Brief Summary: A Phase IV, randomized, multicenter trial to assess the immunogenicity and safety of BioThrax® in varying dose regimens with the primary objective of obtaining information on possible dose-sparing strategies in the event of a major biothreat.